Vir Biotechnology VIR 深 沪
等待开盘 09-17 09:30:00 美东时间
4.86
+0.070
+1.46%
华盛通- 最 高4.925
- 今 开4.75
- 成交量 63.26万股
- 最 低 4.75
- 昨 收 4.79
- 总市值 6.76亿
- 52周最高 14.45
- 市盈率 静 --
- 换手率 0.46%
- 52周最低 4.155
- 委 比 -13.30%
- 总股本 1.39亿
- 历史最高 141.01
- 量 比 0.68
- 振 幅 3.65%
- 历史最低 4.155
- 每 手 1
- 风险率 1.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $15 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $15 price target.
09-16 02:39
港股早知道 | 生成式AI带来AI云市场的爆发 宁德时代召开枧下窝锂矿复产会议
生成式AI带来AI云市场的爆发；宁德时代召开枧下窝锂矿复产会议；云锋证券获香港证监会批准可提供虚拟资产交易服务>>
09-10 07:26
SiNtx Technologies Has Received A Notice Of Allowance For A US Patent Titled "ANTIPATHOGENIC FIBROUS MATERIALS (USED ON AN ANTIVIRAL FACE MASK FOR INACTIVATING AND/OR PREVENTING THE TRANSMISSIN OF A VIRUS)"
https://patentcenter.uspto.gov/applications/17839063/ifw/docs
09-06 01:29
美股牛股 | 绩优股狂飙！MongoDB涨超38%；回声星通信再涨15.5%，两日累涨超90%
绩优股狂飙！MongoDB涨超38%，柯尔百货涨超24%；加拿大鹅涨逾16%，控股股东已收到高价私有化要约；回声星通信再涨15.5%，两日累涨超90%>>
08-28 16:43
B of A Securities Upgrades Vir Biotechnology to Buy, Raises Price Target to $14
B of A Securities analyst Geoff Meacham upgrades Vir Biotechnology (NASDAQ:VIR) from Neutral to Buy and raises the price target from $12 to $14.
08-27 23:49
Eli Lilly Co. Q2 FY2025 Earnings Transcript
Eli Lilly delivered a strong Q2 2025 with 38% revenue growth and major clinical milestones, despite a selloff over obesity drug trial data.
08-08 01:44
Vir Biotechnology Launches Final ECLIPSE Trial, Advancing Full Registrational Program For Chronic Hepatitis Delta
ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in patients with
08-06 20:17
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Orthofix anticipates full-year net sales of $808M–$816M while accelerating U.S. spine distributor transition
Earnings Call Insights: Orthofix Medical Inc. (OFIX) Q2 2025 Management View President and CEO Massimo Calafiore stated the company achieved second quarter pro forma net sales of $200.7 million, marki...
08-05 23:18
